Remission of autoimmune diabetes by anti-TCR combination therapies with anti-IL-17A or/and anti-IL-6 in the IDDM rat model of type 1 diabetes
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Remission of autoimmune diabetes by anti-TCR combination therapies with anti-IL-17A or/and anti-IL-6 in the IDDM rat model of type 1 diabetes
Authors
Keywords
-
Journal
BMC Medicine
Volume 18, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-02-28
DOI
10.1186/s12916-020-1503-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Strength in Numbers: Opportunities for Enhancing the Development of Effective Treatments for Type 1 Diabetes—The TrialNet Experience
- (2018) Carla J. Greenbaum et al. DIABETES
- Type 1 Diabetes TrialNet: A Multifaceted Approach to Bringing Disease-Modifying Therapy to Clinical Use in Type 1 Diabetes
- (2018) Polly J. Bingley et al. DIABETES CARE
- First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes
- (2018) Diana L. Cousminer et al. DIABETES CARE
- Type 1 diabetes mellitus: Complex interplay of oxidative stress, cytokines, gastrointestinal motility and small intestinal bacterial overgrowth
- (2018) Aastha Malik et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Targeting IL-6 or IL-6 Receptor in Rheumatoid Arthritis: What’s the Difference?
- (2018) Ali Berkant Avci et al. BIODRUGS
- Profile of sarilumab and its potential in the treatment of rheumatoid arthritis
- (2017) Maria Gabriella Raimondo et al. Drug Design Development and Therapy
- Therapeutic Targeting of IL-17 and IL-23 Cytokines in Immune-Mediated Diseases
- (2016) George E. Fragoulis et al. Annual Review of Medicine
- Targeting IL-17 in autoimmunity and inflammation
- (2016) Byung-Seok Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Anti cytokine therapy in chronic inflammatory arthritis
- (2016) Charlotte Thompson et al. CYTOKINE
- Reversal of Diabetes in NOD Mice by Clinical-Grade Proinsulin and IL-10–Secreting Lactococcus lactis in Combination With Low-Dose Anti-CD3 Depends on the Induction of Foxp3-Positive T Cells
- (2016) Tatiana Takiishi et al. DIABETES
- Depletion of regulatory T cells leads to an exacerbation of delayed-type hypersensitivity arthritis in C57BL/6 mice that can be counteracted by IL-17 blockade
- (2016) Sara Marie Atkinson et al. Disease Models & Mechanisms
- Phospholipase D enzymes facilitate IL-17- and TNFα-induced expression of proinflammatory genes in rheumatoid arthritis synovial fibroblasts (RASF)
- (2016) Sean C. Friday et al. IMMUNOLOGY LETTERS
- Tofacitinib attenuates pathologic immune pathways in patients with psoriasis: A randomized phase 2 study
- (2016) James Krueger et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis
- (2016) Natasha Whibley et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Effect of IL-17 receptor A blockade with brodalumab in inflammatory diseases
- (2016) Ajay Nirula et al. RHEUMATOLOGY
- Efficacy of Immunobiologic and Small Molecule Inhibitor Drugs for Psoriasis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
- (2016) André Vicente Esteves de Carvalho et al. Drugs in research & development
- Secukinumab for ankylosing spondylitis and psoriatic arthritis
- (2016) Ennio Lubrano et al. Therapeutics and Clinical Risk Management
- Anti-IL-17 Medications Used in the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review
- (2015) Theresa N. Canavan et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- IL-6 inhibitors for treatment of rheumatoid arthritis: past, present, and future
- (2015) Go Woon Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Biological effects of interleukin-6: Clinical applications in autoimmune diseases and cancers
- (2015) Ling-Jun Ho et al. BIOCHEMICAL PHARMACOLOGY
- TNF-α Antibody Therapy in Combination With the T-Cell–Specific Antibody Anti-TCR Reverses the Diabetic Metabolic State in the LEW.1AR1-iddmRat
- (2015) Anne Jörns et al. DIABETES
- A novel Dock8 gene mutation confers diabetogenic susceptibility in the LEW.1AR1/Ztm-iddm rat, an animal model of human type 1 diabetes
- (2015) Tanja Arndt et al. DIABETOLOGIA
- Combination immunotherapies for type 1 diabetes mellitus
- (2015) Paolo Pozzilli et al. Nature Reviews Endocrinology
- Th17 and regulatory T cell balance in autoimmune and inflammatory diseases
- (2014) Mélissa Noack et al. AUTOIMMUNITY REVIEWS
- Combination therapy for preservation of beta cell function in Type 1 diabetes: New attitudes and strategies are needed!
- (2014) Johnny Ludvigsson IMMUNOLOGY LETTERS
- Lessons from Type 1 Diabetes for Understanding Natural History and Prevention of Autoimmune Disease
- (2014) Kimber Simmons et al. RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
- IL-6 in Inflammation, Immunity, and Disease
- (2014) T. Tanaka et al. Cold Spring Harbor Perspectives in Biology
- Differential developmental requirement and peripheral regulation for dermal Vγ4 and Vγ6T17 cells in health and inflammation
- (2014) Yihua Cai et al. Nature Communications
- Anti-cytokine therapies in T1D: Concepts and strategies
- (2013) Gerald T. Nepom et al. CLINICAL IMMUNOLOGY
- Anti-IL-6 Treatment for Inflammatory Bowel Diseases: Next Cytokine, Next Target
- (2013) Mariangela Allocca et al. CURRENT DRUG TARGETS
- IL-17A increases the expression of proinflammatory chemokines in human pancreatic islets
- (2013) Fabio A. Grieco et al. DIABETOLOGIA
- Islet infiltration, cytokine expression and beta cell death in the NOD mouse, BB rat, Komeda rat, LEW.1AR1-iddm rat and humans with type 1 diabetes
- (2013) Anne Jörns et al. DIABETOLOGIA
- Type 1 diabetes
- (2013) Mark A Atkinson et al. LANCET
- Serum levels of IL-17A in patients with relapsing–remitting multiple sclerosis treated with interferon-β
- (2012) Rodica Bălaşa et al. Multiple Sclerosis Journal
- Differential effects of proinflammatory cytokines on cell death and ER stress in insulin-secreting INS1E cells and the involvement of nitric oxide
- (2011) Stella Kacheva et al. CYTOKINE
- Peripheral and Islet Interleukin-17 Pathway Activation Characterizes Human Autoimmune Diabetes and Promotes Cytokine-Mediated -Cell Death
- (2011) S. Arif et al. DIABETES
- Anti-CD3 antibodies for type 1 diabetes: beyond expectations
- (2011) Jean-François Bach LANCET
- Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy
- (2011) Der-Yuan Chen et al. ARTHRITIS RESEARCH & THERAPY
- Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group
- (2010) J. B. Matthews et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass
- (2010) B. Keymeulen et al. DIABETOLOGIA
- T Regulatory Cells Maintain Intestinal Homeostasis by Suppressing γδ T Cells
- (2010) Sung-Gyoo Park et al. IMMUNITY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now